49 results on '"Funnell, Simon"'
Search Results
2. Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays
3. Animal models for COVID-19
4. Evaluation of the neutralising antibody response in human and hamster sera against SARS-CoV-2 variants up to and including BA.2.86 using an authentic virus neutralisation assay
5. Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19
6. Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity
7. A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells
8. Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development
9. The Omicron Sub-Variant BA.4 Displays a Remarkable Lack of Clinical Signs in a Golden Syrian Hamster Model of SARS-CoV-2 Infection
10. Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant
11. Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development
12. Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development
13. SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum
14. Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents
15. Mechanisms of colonisation of mammalian tissues by Bordetella pertussis
16. The Cynomolgus Macaque Intestinal Mycobiome Is Dominated by the Kazachstania Genus and K. pintolopesii Species
17. Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation
18. Advances and gaps in SARS-CoV-2 infection models
19. A Fungal Foray in an NHP Gut Microbiome
20. Advances and gaps in SARS-CoV-2 infection models
21. Convalescence from prototype SARS-CoV-2 protects Syrian hamsters from disease caused by the Omicron variant
22. Dose-dependent response to infection with Ebola virus in the ferret model and evidence of viral evolution in the eye.
23. Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques
24. Distribution and genetic diversity of the ABC transporter lipoproteins PiuA and PiaA within Streptococcus pneumoniae and related streptococci
25. Immunological and pathological outcomes of SARS-CoV-2 challenge after formalin-inactivated vaccine immunisation of ferrets and rhesus macaques
26. Comparison of Rhesus and Cynomolgus macaques as an authentic model for COVID-19
27. Dose-dependent response to infection with SARS-CoV-2 in the ferret model: evidence of protection to re-challenge
28. Antiviral Screening of Multiple Compounds against Ebola Virus
29. Consensus on the development of vaccines against naturally acquired melioidosis
30. Repeated high-dose (5 × 108TCID50) toxicity study, of a third generation smallpox vaccine (IMVAMUNE), in New Zealand white rabbits
31. Assessment of the Protective Effect of Imvamune and Acam2000 Vaccines against Aerosolized Monkeypox Virus in Cynomolgus Macaques
32. Genome Sequence of Burkholderia pseudomallei NCTC 13392
33. Clinical Definitions of Melioidosis
34. Repeated high-dose (5 × 10 TCID 50 ) toxicity study of a third generation smallpox vaccine (IMVAMUNE) in New Zealand white rabbits.
35. Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine
36. PiuA and PiaA, iron uptake lipoproteins ofStreptococcus pneumoniae, elicit serotype independent antibody responses following human pneumococcal septicaemia
37. Recombinant Neisseria meningitidis Transferrin Binding Protein A Protects against Experimental Meningococcal Infection
38. A novel adherence assay forBordetella pertussisusing tracheal organ cultures
39. Intranasal infection of infant mice with Neisseria meningitidis
40. PiuA and PiaA, iron uptake lipoproteins of Streptococcus pneumoniae, elicit serotype independent antibody responses following human pneumococcal septicaemia
41. Recombinant Neisseria meningitidisTransferrin Binding Protein A Protects against Experimental Meningococcal Infection
42. Clinical Definitions of Melioidosis.
43. Book Reviews.
44. LETTERS.
45. YOUR SAY….
46. A novel adherence assay for Bordetella pertussis using tracheal organ cultures
47. An in vitro multi-organ microphysiological system (MPS) to investigate the gut-to-brain translocation of neurotoxins.
48. Repeated high-dose (5 × 10(8) TCID50) toxicity study of a third generation smallpox vaccine (IMVAMUNE) in New Zealand white rabbits.
49. Consensus on the development of vaccines against naturally acquired melioidosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.